Department of Anesthesia, Children's Hospital of Fudan University, 399 Wanyuan Road, Shanghai, 201102, China.
BMC Anesthesiol. 2021 Feb 8;21(1):41. doi: 10.1186/s12871-021-01263-3.
It has been proposed that the dose of rescue opioids should be individually titrated to the severity of obstructive sleep apnea after adenotonsillectomy. However, a sleep study is not always available before adenotonsillectomy. This randomized, controlled and blinded trial evaluated a strategy of pain control individualized to the results of a fentanyl test, rather than the results of polysomnography, in children after adenotonsillectomy.
A total of 280 children (3-10 years old) undergoing elective adenotonsillectomy were randomized into an individualized protocol (IP) group or a conservative protocol (CP) group. All patients received a fentanyl test before extubation. Pain was assessed every 10 min in the recovery room, and rescue morphine was given when the Children's Hospital of Eastern Ontario Pain Scale (CHEOPS) score was > 6. In the IP group, the dose of rescue morphine was individualized to the results of the fentanyl test (10 μg/kg in the case of a positive result and 50 μg/kg in the case of a negative result). In the CP group, the dose was fixed (25 μg/kg). The primary outcome was the percentage of patients requiring at least one medical intervention. The secondary outcome was the median duration of CHEOPS scores > 6.
Fewer patients in the IP group than in the CP group required medical interventions [11.9% (16/134) vs 22.3% (29/130), P = 0.025]. The median duration of CHEOPS scores > 6 was shorter in the IP group than in the CP group [20 (95% CI: 17 to 23) min vs 30 (95% CI: 28 to 32) min, P < 0.001].
Compared with a conservative dosing approach, this individualized protocol may improve analgesia without a significant increase in respiratory adverse events.
ClinicalTrials.gov NCT02990910 , registered on 13/12/2016.
有人提出,在腺样体扁桃体切除术后,应根据阻塞性睡眠呼吸暂停的严重程度个体化滴定解救类阿片药物的剂量。然而,在腺样体扁桃体切除术前并不总是能进行睡眠研究。本随机、对照、盲法试验评估了一种疼痛控制策略,该策略根据芬太尼试验的结果个体化给药,而不是根据多导睡眠图的结果个体化给药,用于腺样体扁桃体切除术后的儿童。
共 280 名(3-10 岁)择期行腺样体扁桃体切除术的儿童被随机分为个体化方案(IP)组或保守方案(CP)组。所有患者在拔管前均接受芬太尼试验。在恢复室中每 10 分钟评估一次疼痛,并在儿童东部安大略省疼痛量表(CHEOPS)评分>6 时给予吗啡解救。在 IP 组中,吗啡解救剂量根据芬太尼试验的结果个体化给药(阳性结果时 10μg/kg,阴性结果时 50μg/kg)。CP 组中,剂量固定(25μg/kg)。主要结局为需要至少一次医学干预的患者比例。次要结局为 CHEOPS 评分>6 的中位持续时间。
与 CP 组相比,IP 组需要医学干预的患者比例更少[11.9%(16/134)vs 22.3%(29/130),P=0.025]。IP 组 CHEOPS 评分>6 的中位持续时间短于 CP 组[20(95%CI:17 至 23)min 比 30(95%CI:28 至 32)min,P<0.001]。
与保守给药方案相比,这种个体化方案可能在不增加呼吸不良事件的情况下改善镇痛效果。
ClinicalTrials.gov NCT02990910,于 2016 年 12 月 13 日注册。